Description
Special instructions
Patients with severe hepatic insufficiency during treatment with the drug should remain under constant supervision.
Considering the possibility of pregnancy, peri-menopausal and early postmenopausal women during treatment with the drug should use reliable methods of contraception until stable postmenopausal hormone levels are established.
Effects on ability to drive and use machines
Some of the drug’s side effects, such as general weakness and dizziness, may affect the ability to drive and perform potentially dangerous activities requiring increased concentration and rapid psychomotor reactions. Therefore, caution should be exercised when driving and working with mechanisms.
Release form/dosing
Film-coated tablets, 2.5 mg.
Packaging
10 tablets each in a moulded polyvinyl chloride film pack and printed lacquered aluminium foil. 30 tablets each in polymer medicinal product jars.
Reviews
There are no reviews yet.